Hemorrhagic Fever, Ebola

"Hemorrhagic Fever, Ebola" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A highly fatal, acute hemorrhagic fever, clinically very similar to MARBURG VIRUS DISEASE, caused by EBOLAVIRUS, first occurring in the Sudan and adjacent northwestern (what was then) Zaire.

Descriptor ID	D019142
MeSH Number(s)	C02.782.417.415 C02.782.580.250.400
Concept/Terms	Hemorrhagic Fever, Ebola Hemorrhagic Fever, Ebola Ebola Infection Infection, Ebola Ebola Virus Infection Infection, Ebola Virus Virus Infection, Ebola Ebola Hemorrhagic Fever Ebola Virus Disease

Below are MeSH descriptors whose meaning is more general than "Hemorrhagic Fever, Ebola".

Diseases [C]
Virus Diseases [C02]
RNA Virus Infections [C02.782]
Hemorrhagic Fevers, Viral [C02.782.417]
Hemorrhagic Fever, Ebola [C02.782.417.415]
Mononegavirales Infections [C02.782.580]
Filoviridae Infections [C02.782.580.250]
Hemorrhagic Fever, Ebola [C02.782.580.250.400]

Below are MeSH descriptors whose meaning is related to "Hemorrhagic Fever, Ebola".

Below are MeSH descriptors whose meaning is more specific than "Hemorrhagic Fever, Ebola".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hemorrhagic Fever, Ebola" by people in this website by year, and whether "Hemorrhagic Fever, Ebola" was a major or minor topic of these publications.

Bar chart showing 27 publications over 9 distinct years, with a maximum of 7 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2015	7	0	7
2016	3	0	3
2017	2	1	3
2018	4	0	4
2019	4	0	4
2020	1	0	1
2021	2	0	2
2022	1	0	1
2023	2	0	2

Below are the most recent publications written about "Hemorrhagic Fever, Ebola" by people in Profiles.

To A, Wong TAS, Ball AH, Lieberman MM, Yalley-Ogunro J, Cabus M, Nezami S, Paz F, Elyard HA, Borisevich V, Agans KN, Deer DJ, Woolsey C, Cross RW, Geisbert TW, Donini O, Lehrer AT. Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection. Vaccine. 2024 Jan 25; 42(3):598-607.

View in: PubMed
Dyal J, Kofman A, Kollie JZ, Fankhauser J, Orone R, Soka MJ, Glaybo U, Kiawu A, Freeman E, Giah G, Tony HD, Faikai M, Jawara M, Kamara K, Kamara S, Flowers B, Kromah ML, Desamu-Thorpe R, Graziano J, Brown S, Morales-Betoulle ME, Cannon DL, Su K, Linderman SL, Plucinski M, Rogier E, Bradbury RS, Secor WE, Bowden KE, Phillips C, Carrington MN, Park YH, Martin MP, Aguinaga MDP, Mushi R, Haberling DL, Ervin ED, Klena JD, Massaquoi M, Nyenswah T, Nichol ST, Chiriboga DE, Williams DE, Hinrichs SH, Ahmed R, Vonhm BT, Rollin PE, Purpura LJ, Choi MJ. Risk Factors for Ebola Virus Persistence in Semen of Survivors in Liberia. Clin Infect Dis. 2023 02 08; 76(3):e849-e856.

View in: PubMed
Williams CA, Wong TAS, Ball AH, Lieberman MM, Lehrer AT. Maternal Immunization Using a Protein Subunit Vaccine Mediates Passive Immunity against Zaire ebolavirus in a Murine Model. Viruses. 2022 12 14; 14(12).

View in: PubMed
Lehrer AT, Chuang E, Namekar M, Williams CA, Wong TAS, Lieberman MM, Granados A, Misamore J, Yalley-Ogunro J, Andersen H, Geisbert JB, Agans KN, Cross RW, Geisbert TW. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses. Front Immunol. 2021; 12:703986.

View in: PubMed
Preston KB, Wong TAS, To A, Tashiro TE, Lieberman MM, Granados A, Feliciano K, Harrison J, Yalley-Ogunro J, Elyard HA, Donini O, Lehrer AT, Randolph TW. Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant. Vaccine. 2021 09 15; 39(39):5650-5657.

View in: PubMed
Preston KB, Monticello CR, Wong TAS, To A, Donini O, Lehrer AT, Randolph TW. Preservation of Quaternary Structure in Thermostable, Lyophilized Filovirus Glycoprotein Vaccines: A Search for Stability-Indicating Assays. J Pharm Sci. 2020 12; 109(12):3716-3727.

View in: PubMed
Younan P, Santos RI, Ramanathan P, Iampietro M, Nishida A, Dutta M, Ammosova T, Meyer M, Katze MG, Popov VL, Nekhai S, Bukreyev A. Ebola virus-mediated T-lymphocyte depletion is the result of an abortive infection. PLoS Pathog. 2019 10; 15(10):e1008068.

View in: PubMed
Mbala-Kingebeni P, Aziza A, Di Paola N, Wiley MR, Makiala-Mandanda S, Caviness K, Pratt CB, Ladner JT, Kugelman JR, Prieto K, Chitty JA, Larson PA, Beitzel B, Ayouba A, Vidal N, Karhemere S, Diop M, Diagne MM, Faye M, Faye O, Aruna A, Nsio J, Mulangu F, Mukadi D, Mukadi P, Kombe J, Mulumba A, Villabona-Arenas CJ, Pukuta E, Gonzalez J, Bartlett ML, Sozhamannan S, Gross SM, Schroth GP, Tim R, Zhao JJ, Kuhn JH, Diallo B, Yao M, Fall IS, Ndjoloko B, Mossoko M, Lacroix A, Delaporte E, Sanchez-Lockhart M, Sall AA, Muyembe-Tamfum JJ, Peeters M, Palacios G, Ahuka-Mundeke S. Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment. Lancet Infect Dis. 2019 06; 19(6):648-657.

View in: PubMed
Chisholm CF, Kang TJ, Dong M, Lewis K, Namekar M, Lehrer AT, Randolph TW. Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxide. Eur J Pharm Biopharm. 2019 Mar; 136:213-220.

View in: PubMed
Jansen van Vuren P, Ladner JT, Grobbelaar AA, Wiley MR, Lovett S, Allam M, Ismail A, le Roux C, Weyer J, Moolla N, Storm N, Kgaladi J, Sanchez-Lockhart M, Conteh O, Palacios G, Paweska JT. Phylodynamic Analysis of Ebola Virus Disease Transmission in Sierra Leone. Viruses. 2019 01 16; 11(1).

View in: PubMed

People

Explore

Similar Concepts

Top Journals